Manufacturers
What are the elements of innovative, effective medication adherence programs -- and how do they address the underlying causes of non-adherence?
The future of eBV is here. How manufacturers can use AI to help patients start life-changing therapies faster than ever.
Executive Q&A: How to make the annual benefits reverification process as smooth as possible for patients and key stakeholders.
Innovative therapies make innovative patient services essential. Learn how Lash Group helped one manufacturer improve speed and access to therapy with an electronic provider portal for benefit verification and prior authorization.
Patients face a growing number of barriers that can impede medication access and adherence. How can manufacturers help address these hurdles?
/lash-group-mk027-copy-(2).png?h=320&iar=0&w=540&useCustomFunctions=1¢erCrop=1&hash=2F618C58F85B162DE84CC91135638757)
